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Abstract. Three-dimensional tumor models have emerged as valuable
in vitro research tools, though the power of such systems as quantitative reporters of tumor growth and treatment response has not been
adequately explored. We introduce an approach combining a 3-D
model of disseminated ovarian cancer with high-throughput processing of image data for quantification of growth characteristics and cytotoxic response. We developed custom MATLAB routines to analyze
longitudinally acquired dark-field microscopy images containing
thousands of 3-D nodules. These data reveal a reproducible bimodal
log-normal size distribution. Growth behavior is driven by migration
and assembly, causing an exponential decay in spatial density concomitant with increasing mean size. At day 10, cultures are treated
with either carboplatin or photodynamic therapy 共PDT兲. We quantify
size-dependent cytotoxic response for each treatment on a nodule by
nodule basis using automated segmentation combined with ratiometric batch-processing of calcein and ethidium bromide fluorescence
intensity data 共indicating live and dead cells, respectively兲. Both treatments reduce viability, though carboplatin leaves micronodules
largely structurally intact with a size distribution similar to untreated
cultures. In contrast, PDT treatment disrupts micronodular structure,
causing punctate regions of toxicity, shifting the distribution toward
smaller sizes, and potentially increasing vulnerability to subsequent
chemotherapeutic treatment. © 2010 Society of Photo-Optical Instrumentation Engi-

neers. 关DOI: 10.1117/1.3483903兴
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1

Introduction

Three-dimensional 共3-D兲 tumor models have emerged as valuable in vitro research platforms to evaluate tumor growth
properties,1–4 and therapeutic response in a more physiologically relevant manner than monolayer cultures.5–9 In pioneering studies, the Bissel laboratory established in vitro 3-D
breast cancer models in which normal and malignant breast
epithelial cells grown on a bed of growth-factor-reduced
共GFR兲 Matrigel™ form polarized 3-D acinar structures.10
Implementing these 3-D models to understand cell signaling
in relation to position within a acinus, their group and others
were able to make basic tumor biology insights into breast
carcinogenesis and progression, which would not be possible
in monolayer cultures.1–4 Treatment response studies have
shown that cancer cells induced to form 3-D spheroids are
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vastly less sensitive to chemotherapy than monolayer cells.5
Finlay et al.,6 Bigelow et al.,7 Georgakoudi and Foster,8 and
Foster et al.,9 also demonstrated the utility of tumor spheroids
to study dose rate effects and other key determinants of photodynamic therapy 共PDT兲 efficacy. While these reports demonstrate the importance of restoring key architectural cues in
vitro, the full capability of 3-D tumor models as a biologically
relevant platform for analysis of tumor growth and cytotoxic
response has not yet been adequately explored. In vitro 3-D
tumor systems, could, with the appropriate statistical characterization methods, be used as tools to provide a window into
tumor growth mechanisms in vivo, while providing a level of
access for imaging and manipulation of the system that is
difficult to achieve in animal models. Similarly, 3-D models
provide a unique but untapped opportunity to quantify cytotoxic response across large numbers of individual tumor nodules of different sizes in a system where physical variables
1083-3668/2010/15共5兲/051603/10/$25.00 © 2010 SPIE
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such as penetration of drugs through multiple cell layers actually reflect the physiological scenario.
To tap into the inherent capability of in vitro 3-D systems
as reporters of growth properties and cytotoxic response, optical microscopy emerges as a natural research tool. Cultures
can be plated on coverslip bottom dishes or multiwell plates
to allow for imaging with an inverted microscope, which requires no disruption of the sample and is highly conducive to
longitudinal monitoring. In contrast to previous studies examining cellular-level signaling in high-resolution images of
single acini,1–4 here we focus on quantification of large data
sets, by acquisition of microscope fields each containing hundreds of tumor nodules. Model systems such as those just
described, in which cells are overlaid on a basement membrane layer, are particularly conducive to this type of imaging
as 3-D structures are formed in a single focal plane on the
surface of the gel 共as opposed to being embedded inside it兲.
These fields can then be automatically segmented and batch
processed to obtain lists of sizes, eccentricities, and positions
for each nodule. By acquiring sets of images across independently prepared cultures at sequences of time points, evolution of the full size distribution 共rather than just representative
measurements兲 for thousands of 3-D structures can be monitored. Similarly, by using the appropriate fluorescence agents
to stain live and dead cells following cytotoxic treatments,
2-D arrays of pixel data can again be segmented to report
treatment response nodule by nodule, correlating viability
with structural or morphological changes in response to treatment. With appropriate ratiometric quantification, this approach provides a level of sophistication in reporting of cytotoxic response that cannot be achieved with traditional
colorimetric assays in which the viability of an entire culture
dish is reduced to a single number.
In this paper, we utilize this imaging-based approach to
elucidate growth characteristics and patterns of cytotoxic response in an in vitro 3-D model of micrometastatic ovarian
cancer. For the majority of patients, this disease is diagnosed
at a late stage characterized by disseminated studding of the
peritoneal surfaces with tumor nodules ranging in size from
microscopic clusters of a few cells to large cakes of disease
spanning several centimeters.11–13 The low survival rate of
31%, which has improved only marginally over the course of
decades, points to the need for new physiologically relevant
research platforms to meaningfully examine treatment response and devise more effective strategies. We adopt an ovarian cancer model that draws on the established in vitro models of breast cancer in which cells overlaid on a bed of GFR
Matrigel basement membrane spontaneously form 3-D
acini.1,4,10,14,15 In contrast to 3-D ovarian spheroids, which are
grown in rotary culture to prevent adhesion to the underlying
substrate,16,17 this system recapitulates the spontaneous formation of tumor nodules from individual adherent cells. Following a characterization of the growth kinetics in this system,
we examine the response to two mechanistically distinct treatments: carboplatin and PDT. Carboplatin is an established
chemotherapy in clinical use for the treatment of ovarian
cancer.18,19 PDT is a light-based therapy in which wavelengthspecific activation of a photosensitizer generates cytotoxicity
to the illuminated region.20 PDT has demonstrated promise
for treatment of ovarian cancer in clinical and preclinical
Journal of Biomedical Optics

studies, though additional studies are required to establish optimal treatment parameters.21–26

2

Materials and Methods

2.1 Three-Dimensional Cell Culture
Epithelial ovarian cancer NIH:OVCAR-5 cells were obtained
from Thomas Hamilton 共Fox Chase Cancer Institute, Philadelphia, Pennsylvania兲. The cells were grown in RPMI-1640
共Roswell Park Memorial Institute兲 medium 共Mediatech Inc.,
Herndon, Virginia, USA兲 supplemented with 10% heatinactivated fetal calf serum 共GIBCO Life Technologies,
Grand Island, New York, USA兲, 100 U / mL penicillin, and
100 g / mL streptomycin. For 3-D cell culture, growth factor
reduced 共GFR兲 Matrigel 共BD Biosciences, San Jose, California兲 was used as a basement membrane, which has appropriate gel structure and established biological activity to promote
growth and differentiation of a variety of cells.27 To prepare
3-D cultures 500-L volumes of NIH:OVCAR-5 cells in
single cell suspension of 15,000 cells/ mL were grown on
beds of GFR Matrigel 共BD Biosciences兲 on the glass slide
inset of 35-mm MatTek culture dishes 共MatTek Corporation,
Ashland, Massachusetts, USA兲. GFR Matrigel beds were initially prepared by ejecting 150 L of GFR Matrigel solution
at ⬃4 ° C on the chilled MatTek plates and carefully rotating
the dish at a slight angle to evenly distribute it over the
10-mm-radius glass portion of the MatTek dishes that were
then incubated at 37 ° C for 30 min prior to plating cells to
allow gelation to occur. Following initial plating of cells, they
were allowed to adhere to the Matrigel bed before addition of
complete growth medium with 2% GFR Matrigel. All cultures
were maintained in an incubator at 37 ° C in an atmosphere of
5% CO2.
2.2 Microscopy for Growth Characterization
To characterize development of size distributions over time,
3-D cultures were routinely imaged by darkfield microscopy
at 5⫻ using a Zeiss Axiovert inverted microscope 共Carl Zeiss
MicroImaging, Inc., Thornwood, NY, USA兲 fitted with a
QuantiFIRE™ cooled 12-bit monochrome CCD camera with
2048 ⫻ 2048-pixel chip 共Optronics, Goleta, California兲. Images were acquired in a focal plane just above the surface of
the gel on which 3-D structures are formed. For each plate,
five dark-field images of each culture dish were acquired at
each time point in the tagged image file format 共TIFF兲 and
saved for off-line processing. Time-lapse microscopy sequences were obtained using a Nikon TE2000-S inverted microscope with a 10⫻ phase contrast objective in an enclosed
weather station 共Nikon Instruments, Inc, Melville, New York,
USA兲.
2.3 Image Processing for Growth Analysis
Image data was processed using custom scripts developed using the Image Processing Toolbox in the MATLAB software
package 共Mathworks, Natick, Massachusetts, USA兲. To calculate size distributions from image data we developed a batch
analysis routine in which sets of high-contrast dark-field images were thresholded 共calling on a built-in automated routine
based on Otsu’s method兲, made binary and segmented to identify in vitro nodules. The routine would count the number of
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pixels in each region while rejecting partial features at the
edge of each field of view and calibrate sizes to square micrometers. Features of size less than 200 m2 were rejected.
Lists of statistics for each feature 共size in square micrometers,
equivalent diameter in micrometers, eccentricity, and the x
and y positions in the image兲 were tabulated and grouped by
time point. Size distribution histograms were then generated
from lists of sizes at each time point. In general we report size
in units of square micrometers as 2-D cross-sectional area A,
which is directly reported from calibration of pixel counts,
and strictly speaking, is the most accurate quantification of
size. However, nodules are approximately spherical and it is a
reasonable approximation to calculate equivalent diameter deq
as a more intuitive metric of nodule size, which is obtained
from area by 共deq / 2兲2 = A.
Image data were grouped into directories by imaging time
point so that all routines were run as batch processes, enabling
rapid generation of statistics on large lists of micronodules at
each time point. The same automated segmentation approach
was used to analyze the size distribution of residual viable
disease following treatment by application of the same batch
process to sets of calcein green fluorescence image data, as
described in the following. To verify the accuracy and precision of high-throughput automated image segmentation approximately 1 out of every 50 images was randomly selected
for manual verification by having MATLAB overlay arrows at
each software-identified nodule centroid. This comparison of
manual identification to software identification in the images
tested revealed a 97.3% rate of agreement for positive identification of features. Additional data analysis and graphing of
image data including multipeak nonlinear least-squares
Gaussian curve fits was conducted using the Origin software
package 共OriginLab Corporation, Northampton, Massachusetts兲.

2.4 Carboplatin Treatments
Carboplatin treatments were performed by incubating 3-D
cultures in OVCAR-5 complete culture medium with 1 mM
carboplatin 共Teva Pharmaceuticals, Petach Tikva, Israel兲 for a
total of 96 h, including a carboplatin media refresh at 48 h.
This dose was selected based on calculation of the concentration with respect to the area of the culture dish to provide a
dosage estimated to be equivalent to the clinical dose of
400 mg/ m2, which was reported to be effective in human
patients.18 Treatment response was assessed immediately after
removal of carboplatin media as described in the following.
2.5 PDT Treatments
At day 10 following plating, cultures were incubated with
250 nM BPD-MA 共or Verteporfin, QLT, Inc., Vancouver, British Columbia, Canada兲 in complete culture media for 90 min.
Immediately prior to irradiation, the media were replaced with
regular complete media. Laser irradiation was delivered
through the bottom of each culture dish on a clear plastic tray
via a vertically mounted Thorlabs FT600EMT multimode fiber 共Thorlabs, Newton, New Jersey, USA兲, which was collimated to overfill the dish area to deliver light nearly uniformly over the central 1-cm-radius portion of a MatTek dish
containing the Matrigel layer with 3-D nodules on the surface.
Irradiation times were calculated to achieve total fluence of
Journal of Biomedical Optics

10 J / cm2 at a fluence rate of 50 mW/ cm2, which was measured using an Ophir Vega power meter with photodiode sensor 共Ophir Optronics, Israel兲 prior to each experiment. After
treatments, cultures were returned to the incubators for 24 h
prior to assessment of treatment response.
2.6 Imaging-Based Assessment of Cytotoxic Response
Assessment of cytotoxic response in the 3-D culture model
posed an additional challenge as the conversion products from
traditional MTT and MTS assays were found to adhere to the
Matrigel substrate preventing reliable reporting of viability by
these methods. To overcome this we developed a quantitative fluorescence-imaging-based approach using the
LIVE/DEAD® cytotoxicity kit 共Invitrogen Corporation, Carlsbad, California, USA兲. Media was removed from culture
dishes of 3-D nodules by gentle aspiration followed by a wash
with phosphate-buffered saline 共PBS兲 and incubation at
37 ° C for 40 min with 2 M calcein AM and 4 M
ethidium homodimer-1 共Invitrogen兲 diluted in PBS prior to
imaging. Addition of reagents to each culture dish was staggered such that the incubation period was exactly 40 min for
each dish. Following incubation, three digital images were
acquired by sequentially rotating filter cubes on a Zeiss Axiovert 100 TV inverted microscope 共Zeiss, Germany兲 at each of
four spatial fields imaged in each culture dish: 共1兲 a dark-field
image, 共2兲 a calcein fluorescence emission image
共494/ 517 nm, excitation/emission兲, and 共3兲 an ethidium bromide fluorescence emission image 共528/ 617 nm excitation/
emission on intercalation into DNA兲. All images were acquired using a 5⫻ objective in inverted geometry imaging
through the glass window on the bottom of each MatTek culture dish and collecting light from the focal plane on which
3-D cultures were grown on the surface of the Matrigel bed.
Images were captured with a CCD camera 共Quantifire XI,
Optronix, Israel兲 and saved as 12-bit TIFFs for later analysis.
Again, using a batch-process routine developed in the MATLAB software package, sets of images were analyzed in high
throughput to report the mean fluorescence signal from the
calcein and ethidium bromide channels with the ratio of calcein fluorescence to total fluorescence 共calcein plus ethidium兲
as a reporter of viability. The ratio was computed in this manner for all treatment groups. To make comparisons between
carboplatin and PDT treatments assessed at different imaging
sessions, values were normalized to the respective notreatment control group to calculate percentage viability for
each treatment following standard general practice for quantification of cytotoxic response by any method. This routine
was then run inside the size distribution code already discussed to identify each nodule in a corresponding dark-field
image of a given field and then calculate the viability based
only on the pixels in that nodule. Iterating over all in vitro
nodules, this method produces lists of hundreds of nodules for
each treatment group for each experimental run, and viability
for each one.
2.7 Immunofluorescence Protocol
The 3-D cultures were stained following a protocol previously
described by Debnath and Brugge.1 To prevent the degradation of the Matrigel during the staining protocol and subsequent loss of 3-D nodules from the Matrigel surface, culture
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dishes were maintained at 37 ° C between all steps. The exchange of buffers and staining solutions was accomplished
using a micropipetter to minimize disruption of the Matrigel.
Anti-E-cadherin antibodies 共BD Transduction Laboratories,
BD Bioseciences, San Jose, California, USA兲 were conjugated with Alexa Fluor 568 labeled goat antimouse 共Invitrogen兲 for targeted E-cadherin molecular imaging. DAPI
共4⬘ , 6-diamidino-2-phenylindole兲 was obtained from Sigma
and diluted accordingly. Images were obtained using an
Olympus FV1000 confocal microscope 共Olympus of America,
Inc., Center Valley, Pennsylvania, USA兲.

3

Results and Discussion

3.1 Growth Characterization
OVCAR-5 human ovarian cancer cells plated on GFR Matrigel formed solid, multicellular 3-D acini that reached sizes of
the order of ⬃110 m in diameter by 10 days following plating, consistent with previously reported observations from optical coherence tomography 共OCT兲 imaging of individual
nodules plated by the same method.28 We observed that the
physical characteristics of the 3-D acini 共Fig. 1兲 was highly
varied, with structures ranging from clusters of just a few
cells to large acini to caked aggregates of multiple acini,
qualitatively resembling the heterogeneity of micronodular
disease in vivo.23 To quantify growth kinetics in this system,
multiple independently plated batches were longitudinally imaged by dark-field microscopy 共providing high-contrast images conducive to processing兲 at regular intervals for up to
24 days following initial plating. To obtain statistically significant data sets, large fields of view containing 共initially兲 of
the order 200 cells were obtained using a 5⫻ objective. For
each independently plated culture, five fields of view were
obtained for each time point and saved into directories organized by time point. Using image processing routines developed in the MATLAB software package, we batch-processed
these large sets of dark-field microscopy image data to produce lists of statistics for thousands of individual 3-D acini at
multiple time points. We observed that the distribution of acinar sizes was initially homogeneous through days 3 to 4, but
consistently broadened at late time points with a significant
fraction of acini with sizes from 200 to 400 m2 共in crosssectional area from 2-D microscopy data兲 but with numerous
larger acini with sizes up to 400,000 m2. As this skewed
distribution of sizes suggested a log-normal distribution we
generated histograms for each time point with logarithmically
共base 2兲 spaced bins 共Fig. 1兲 consistent with the basic premise
that growth processes are driven by multiplicative, rather than
additive events.29 In these histograms, we consistently observed the emergence of two log-normal modes at later time
points fitting well to a two-peak Gaussian model of the form

冋

共s⬘ − sc1兲2
f 共 s ⬘兲 =
exp −
w21
w1冑/2
A1

+

A2

w2冑/2

where
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冋

exp −

册

册

共s⬘ − sc2兲2
,
w22

共1兲

Fig. 1 Representative dark-field microscopy images of in vitro 3-D
acini and corresponding size distribution histograms and Gaussian fits
from analysis of image data obtained at 共a兲 day 3 following plating
and 共b兲 day 7, 共c兲 day 10, and 共d兲 day 17. The n values on the right of
each histogram indicate the number of nodules included in each histogram. Scale bars= 250 m.

s⬘ = log2

冉 冊

s
,
100

共2兲

and A, w, and sc are amplitude, width, and center position of
each peak, respectively. This bimodal form indicates the presence of two distinct growth behaviors. These distinct growth
modes correspond to a population of cells in which Sc1 remains constant over time, corresponding to a constant equivalent diameter of ⬃20 m over the time probed. The other
peak, with position Sc2, shifts to the right at subsequent imaging time points corresponds to a more rapidly assembling
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subdistribution of micronodules with mean equivalent diameters deq of 92, 120, and 150 m at days 7, 10, and 17,
respectively 关Figs. 1共b兲–1共d兲兴. Extrapolating the constant position of Sc1 back to the day 3 image data and subjecting it to
the same two-peak model 共even though the distribution initially appears to have only one peak兲, we found that the nonlinear least-squares curve fit rapidly converged, indicating that
this bimodal behavior also describes the early time points following plating. The other fit parameters associated with the
population of the more aggressive growth mode also seem to
have time dependent behavior, with w2 monotonically increasing, while A2 monotonically decreases over the time
probed 共but with the area under the peak remaining roughly
constant兲. In contrast, the width and amplitude of the smaller
size peak, w1 and A1, respectively, remain roughly constant.
Size distributions at individual time points were also compared across individual culture dishes and dates of plating,
and no statistically significant systematic variations were observed 共p value⬎ 0.1 in two-tailed t test comparison of size
lists between plates兲. The bimodal distribution was observed
in all dishes with separable peaks observed in approximately
the same positions in all cases with p value⬍ 0.001 in a twotailed Student’s t test comparison of sets of sc1 and sc2 values
calculated from each independently plated culture imaged at a
given time point 共three to nine cultures depending on the time
point兲. Conversely, comparison of lists of sc1 values derived
from different time points show no significance 共p value
⬎ 0.1, indicating that indeed this peak is reproducibly centered in the same position兲, while sc2 shifts significantly between days 7 and 17 with p value= 0.01.
To examine these growth properties in real time, we conducted a series of time-lapse microscopy experiments in
which 3-D cultures grown in multiwell plates were imaged at
10-min intervals over the course of several days. Individual
snapshots from several timepoints of the full sequence are
shown in Fig. 2. Observation of the behavior of individual
cells over an extended period in time lapse sequences supports the observation of two growth behaviors; one population
of cells rapidly merged together forming larger and larger
multicellular aggregates 关yellow arrows in Fig. 2共a兲 exemplify
this behavior兴 while another appeared to be dominated by
slow proliferation with little or no evidence of motility and
assembly 关the cell in the green box in Fig. 2共a兲 is consistent
with this behavior兴. The complete time-lapse sequence from
which these frames were obtained is shown in the video.
These observations give rise to the model shown schematically in Fig. 2共b兲, indicating a rapidly comigrating group of
cells 共beige兲 juxtaposed with another group of cells 共⬃30% as
indicated from frequency counts above兲 that exhibit little motility or affinity for assembly with surrounding cells, regardless of proximity. The rapid migration and assembly behavior
gives rise to an overall exponential decay in the spatial density of acini 关Fig. 2共c兲兴 that is concomitant with increasing
size 关Fig. 2共d兲兴 in the population of larger and more aggressively growing micronodules. It is not surprising that this behavior seems to dominate as from the frequency counts in Fig.
2 we would expect ⬃70% of the cells in a given field to
follow the high-motility migration and assembly kinetics. The
decay is of the form n共t兲 = n0 + A exp共−t / 兲, where
 = 5.9 days−1.
Journal of Biomedical Optics

The heterogeneity observed here qualitatively resembles
the distribution of large and small nodules in peritoneal studding in vivo.23 These highly divergent behaviors, as evidenced
by the differing propensities of the cells to migrate and assemble, suggest that even within a single cell line, the 3-D
model reveals heterogeneity in growth properties and possibly
response to treatment that are not apparent in monolayer cultures. Further studies are warranted to correlate these contrasting behaviors with relevant molecular markers and also to
compare distributions of nodular size in this in vitro system
with actual patient tissues. A more complete mathematical
description of the combined aggregation and cell division kinetics underlying the formation of multicellular structures in
this 3-D model system is part of an ongoing study.

3.2 Analysis of Carboplatin Treatment Response in
3-D Nodules
To demonstrate the value of our system as a tool to assess
treatment outcome we conducted treatment response studies
with carboplatin, a clinically relevant chemotherapeutic used
to treat ovarian cancer. In preliminary studies, we found that
viability in 3-D could not be assessed by traditional colorimetric assays as adhesion of the converted products to the
Matrigel substrate obfuscated fluorescence or absorbance
readings correlated with viability. For this reason the commercially available LIVE/DEAD fluorescence imaging kit 共Invitrogen L3224兲, which stains live cells and dead cells with a
pair of fluorophores 共calcein and ethidium bromide, with fluorescence emission in the green and red, respectively兲 was
adapted into a quantitative tool to assess cell viability as described in Sec. 2. This imaging-based approach for quantitative assessment of cytotoxic response has several valuable
features, as demonstrated in the following. Specifically, because we have access to a full 2-D array of pixel intensities
共rather than a global average兲 we can combine the ratiometric
quantification of viability from fluorescence intensities with
the automated image segmentation 共used for batch analysis of
size distributions兲 to analyze cytotoxic response nodule by
nodule. This approach provides a depth of insight into patterns of response, by size and morhphology of nodules that
colorimetric assays cannot provide.
Cultures were allowed to grow to day 10 at which time
treatment was initiated. Upon visual inspection of cultures
stained with LIVE/DEAD reagents 关Fig. 3共a兲兴 it is apparent
that there is a clear cytotoxic response 共larger and more intense regions of red ethidium bromide fluorescence relative to
no treatment control兲. The mean viability of 1000 M
carboplatin-treated nodules reported as live signal divided by
total fluorescence signal and normalized to mean no treatment
control viability was 0.22⫾ 0.07 关minimum 0.073, maximum
0.57 Fig. 3共b兲兴. However, even with total exposure to carboplatin for an extended incubation period, cytotoxicity seems
to be primarily localized to the cells on the periphery of each
acinus, with large surviving 共green兲 cores in the center 关Fig.
3共a兲兴. This observation is also apparent from analyzing the
size distribution of residual viable disease from segmentation
of the calcein fluorescence emission images 关Fig. 3共c兲兴, which
is essentially unchanged from the distribution of nodules prior
to initiation of treatment at day 10 关Fig. 1共c兲兴. Size-dependent
treatment response is summarized in Fig. 1共d兲, in which each
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Fig. 2 Characterization and quantification of growth behavior from time lapse microscopy correlated with analysis of longitudinal darkfield image
data 共shown in Fig. 1兲. 共a兲 Individual frames from time-lapse microscopy acquired from 4 h following plating until 4 days following plating 共the full
time-lapse sequence is included as a video兲. Yellow arrows indicate clusters of cells that rapidly migrate over the Matrigel surface and assemble to
form larger multicellular acini. The green box indicates a representative cell that does not participate in assembly events in the immediate vicinity,
but does undergo cell division. Scale bars= 100 m. 共b兲 Schematic representation of the bimodal growth kinetics described in Fig. 1 and 共a兲.
Approximately 30% of cells 共gray兲, exhibit low motility and little potential to migrate toward other clusters of cells. The other 70% of cells 共beige
cells兲 exhibit a much more aggressive growth behavior, rapidly forming larger and larger multicellular aggregates. The sequential numbering 1, 2,
and 3 in the diagram indicates 共1兲 single cells following plating that 共2兲 form small clusters and 共3兲 subsequently form larger multicellular clusters.
Inset: confocal immunofluorescence section from the center of a nodule fixed and stained for E-cadherin 共red兲 and DAPI 共blue兲 at day 10 of growth
to reveal large multicellular 3-D structures formed from assembly and division of individual cells on the gel surface. Scale bar= 20 m. 共c兲
Assembly events lead to an overall decay in the spatial density of 3-D acini with a decay constant of 5.9 days−1. Error bars in 共c兲 are standard
deviations of density measurements from five fields, each of three to nine independent prepared culture dishes imaged at a given time point. 共d兲
Exponential decay in density is concomitant with an increase in mean diameter over time of rapidly growing nodules 关corresponding to sc2 from
Gaussian fits in Fig. 1 and Eq. 共1兲 of the text兴. Mean diameter remains constant in the remaining nodules 关sc1 in Eq. 共1兲兴. Error bars in 共d兲 are derived
from the widths of Gaussian fits shown in Fig. 1. 共QuickTime, 1.45 MB兲 关URL: http://dx.doi.org/10.1117/1.3483903.1兴.
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Fig. 3 Carboplatin treatment response assessed by quantitative ratiometric fluorescence imaging. 共a兲 Representative LIVE/DEAD fluorescence image
of 3-D culture subject to 1000 M carboplatin treatment and corresponding no treatment control grown in identical conditions. The carboplatin
treated plate exhibits a pattern of cytotoxic response in which cores of 3-D nodules remain viable 共green兲 while cells at the periphery are dead.
Display images adjusted with hi-lo lookup table 共all quantitative analysis is based on raw unprocessed images兲. Scale bars= 250 m. 共b兲 Distribution of viabilities in carboplatin treated nodules. Mean viability is 0.22 with standard deviation of 0.07 共minimum value 0.073, maximum value
0.57兲. 共c兲 Size distribution of residual viable disease based on analysis of green 共live兲 channel data of carboplatin-treated cultures by the same
methods used in growth characterization as already described. The distribution resembles the untreated cultures at day 10, indicating growth arrest
during treatment, with the mean diameter of larger nodules approximately the same as untreated day 10 cultures. 共d兲 Combined plot of normalized
viability versus nodule size for 1000 M carboplatin-treated 3-D cultures plotted on the same log scale as 共c兲. Each data point corresponds to an
individual 3-D nodule and is obtained by segmentation of the dark-field image to report size and viability based on intensity data from corresponding fluorescence images of the same spatial field. The bimodal size distribution is readily evident from the two dense clusters of data points
to either side of a sparse region between 1600 and 3200 m2.

data point represents nodule size based on analysis of the
corresponding dark-field channel 共horizontal axis兲 and the viability based on the fluorescence intensity ratio calculated
from the pixels in that nodule 共vertical axis兲. Following carboplatin treatment the size-dependent response appears relatively flat, with all nodules uniformly reduced to a narrowly
distributed range of viabilities. The characteristic bimodal
growth distribution is immediately also evident here from the
two dense clusters of data points to either side of a sparse
region between 1600 and 3200 m2.
The carboplatin treatment response data indicates that although viability is reduced overall, large surviving fractions
of nodules are left behind even after incubation for 4 days
and in a system where the nodules are totally exposed the
agent for the duration of treatment. This could point to a major concern in the clinical scenario, where even submillimeter
Journal of Biomedical Optics

disseminated disease 共which our model system reflects兲 remains after chemotherapy and ultimately regrows and develops drug resistance. This scenario points toward the use of
combination treatment modalities, which enhance the efficacy
of chemotherapy by either improving penetration or increasing the sensitivity of cells prior to treatment.

3.3 Analysis of PDT Treatment Response in 3-D
Nodules
Fluorescence imaging of 3-D cultures subject to 10 J / cm2
BPD-PDT treatment revealed a profoundly different pattern of
response than the chemotherapy treatment 共Fig. 4兲. While
some nodules are mostly viable 共green兲, others are structurally
degraded with pockets of intense ethidium bromide 共red兲 fluorescence throughout. 共Color online only.兲 This pattern is re-

051603-7

September/October 2010

쎲

Vol. 15共5兲

Celli et al.: Quantitative imaging reveals heterogeneous growth dynamics and treatment-dependent…

Fig. 4 Photodynamic therapy treatment response assessed by quantitative ratiometric fluorescence imaging. 共a兲 Representative LIVE/DEAD fluorescence image of 3-D culture subject to 10 J / cm2 BPD-PDT treatment showing a profoundly different pattern of response than the chemotherapy
treatment 共Fig. 3兲. While some nodules are relatively unaffected 共mostly viable, green兲, others are structurally degraded with pockets of deep red
fluorescence throughout. Display images adjusted using the hi-lo lookup table 共all quantitative analysis is based on raw unprocessed images兲. Scale
bars= 250 m. 共b兲 Distribution of viabilities in 10-J / cm2 BPD-PDT treated nodules. Mean viability is 0.46 with standard deviation of 0.29
共minimum value 0.05, maximum value 1.2兲. 共c兲 Size distribution of residual viable disease based on analysis of green 共live兲 channel data of
BPD-PDT treated cultures by the same methods used in growth characterization already described. Although mean viability is higher than in the
case of the 1000 M carboplatin incubation, the distribution is dramatically shifted toward smaller sized nodules. The position of the larger
population peak is shifted to the left with respect to normal growth 关Fig. 1共c兲兴 or carboplatin incubation 关Fig. 3共c兲兴. 共d兲 Plot of normalized viability
versus nodule size in 10-J / cm2 BPD-PDT treated cultures. Each data point corresponds to an individual 3-D nodule and is obtained by segmentation of the dark-field image to report size and viability based on intensity data from corresponding fluorescence images of the same spatial field.
Size-dependent response exhibits a high degree of scattering in the viabilities of small nodules likely generated by disruption of larger nodules
during PDT treatment.

flected in the distribution of viabilities of treated nodules normalized to no treatment control 关Fig. 4共b兲兴. Which has a mean
value of 0.46 with standard deviation of 0.29 共minimum value
0.051, maximum value 1.2兲. Note that since nodule viabilities
are normalized to the mean of the untreated control viabilities,
it is possible for individual nodules to have a value higher
than 1, even though the average is 46% that of the untreated.
In contrast to carboplatin-treated cultures already described,
in which the size distribution post treatment 关Fig. 3共c兲兴 is very
similar to pretreatment 关Fig. 1共c兲兴, the size distribution of residual viable nodules 共calcein green channel兲 following BPDPDT treated cultures is dramatically shifted toward smaller
sized nodules as a result of PDT treatment 关Fig. 4共c兲兴. Integration of the first three histogram bins in Fig. 4共c兲 corresponding to sizes from 200 to 1600 m2 共nodules up to
⬃45 m in diameter兲 shows that nodules in this size range
Journal of Biomedical Optics

account for 68% of the residual disease in the treated culture
dishes as compared to 30% in untreated cultures. This is in
contrast to carboplatin-treated cultures in which the same size
interval accounts for 46% of residual disease, meaning that
more than half of the residual nodules are larger than 45 m
equivalent diameters. To better understand how viability correlates with size for BPD-PDT-treated nodules, normalized
viability is plotted against nodule size 关Fig. 4共d兲兴. The vertical
spread in data points corresponding to small nodules indicates
that this population accounts for the overall high degree of
variability. This suggests that as PDT breaks down the larger
nodules, a portion of the small fractions that come off remain
viable. This observation further points to the potential value
of a combination treatment, using PDT to initially disrupt 3-D
nodules, followed by chemotherapy to kill surviving cells.
The trend evident in the scatter plot from the PDT treatment
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response of larger nodules 共 ⬎ 3000 m2兲 suggests that there
is a size-dependent trend of increasing viability 共decreasing
cytotoxicity兲 with increasing nodule size, though additional
studies are warranted to investigate this further. The ability to
make such insights further points to the value of the quantitative imaging-based approach employed in this study to reveal urgently required new treatment strategies.

4

Conclusions

We demonstrated the utility of an imaging-based approach for
analysis of tumor growth and treatment response in an in vitro
3-D model of micrometastatic ovarian carcinoma. Using this
system, we introduced a model of the mechanism of growth
for adherent cancer cells on Matrigel based on migration and
assembly behavior that led to the development of a bimodal
size distribution of 3-D nodules. The power of the approach
introduced here is its ability to quantitatively evaluate and
identify statistical trends in growth and cytotoxic response in
distributions of micronodules that physically resemble the
size and structure of tumors in physiological conditions. This
system fills a unique niche in the spectrum of translational
science between traditional monolayer cell culture and animal
models. As demonstrated, our in vitro system is highly conducive to longitudinal imaging, requiring only the removal of
culture dishes from incubation for short periods to place them
on and off the microscope stage. While lacking crucial elements of in vivo tumor models such as development of vasculature, the imaging approach here also provides the ability
to look at thousands of “in vivo-like” nodules simultaneously
without need for anesthesia or endoscopy to obtain access. In
future studies, we plan to further leverage this feature of our
platform by carrying out longitudinal monitoring of the evolution of the micronodular size distribution past the treatment
time point to look at longer term tumor regrowth. This will
provide the ability to examine the impact of new interventions
on tumor regrowth to design new strategies to most effectively target the most persistent disease.
This study utilized our in vitro research platform to provide new insights into response of micronodular disease to
carboplatin chemotherapy and PDT. While carboplatin reduces overall viability, even the 96-h incubation with 1 mM
carboplatin leaves significant surviving fractions. Both the visual pattern of cell death and the size distribution of residual
viable disease suggests that carboplatin does not penetrate
into the centers of nodules, inducing cell death primarily at
the periphery. In contrast, we find that BPD-PDT treatment
disrupts in vitro nodules, producing a less dramatic reduction
in viability of each nodule, but breaking larger nodules down
into a more fragmented distribution of smaller nodules and
giving rise to a significant change in the size distribution of
residual nodules. These observations suggest the evaluation of
a combination therapy consisting of PDT to initially disrupt
nodules and enhance efficacy of a subsequent carboplatin
treatment.
The imaging-based research platform introduced here provides a strong foundation to be built on in future studies. The
tumor modeling and imaging tools described could be adapted
to different solid tumor disease models and different treatment
regimens. By incorporation of other cell types such as fibroblasts, endothelial cells, and macrophages, models could be
Journal of Biomedical Optics

developed that more fully recapitulate tumor stroma interactions. Such models could serve as a physiologically relevant
high-throughput drug screening platform to identify the most
promising agents and sequences prior to more costly in vivo
testing. Furthermore, while this study focused on the evaluation of cytotoxic response to treatment, the quantitative batch
processing of fluorescence image data developed here could
be applied to targeted molecular imaging data. This approach
could incorporate multiple channels of fluorescence input acquired in high throughput with an automated x-y positioning
stage, and the analysis could be adapted for similar quantitative analysis of a broad spectrum of molecular markers in 3-D
nodules. In this manner, changes in expression of relevant
biomarkers could be reported in correlation with statistical
changes in size distribution following treatment, providing the
foundation of mechanism-based combination therapies with
improved outcomes.

Acknowledgments
We thank Yupeng Tu and Drs. Bryan Spring, Daniel Neuman,
and Humra Athar of the Wellman Center for Photomedicine,
as well as Dr. Shyamsunder Erramilli of Boston University for
helpful discussions of this work. We thank Dr. David Schoenfeld of the Department of Biostatistics at Massachusetts
General Hospital and Harvard Medical School for his guidance on interpretation of statistical considerations in our results. This work was supported by National Institutes of
Health, Grants R01 AR040352-09, 5R01CA119388-03, and
P01 CA084203-06 共to T.H兲, F32 CA138153 共to C.L.E兲, and
the Wellman Center for Photomedicine Graduate Fellowship
共to I.R兲.
References
1. J. Debnath and J. S. Brugge, “Modelling glandular epithelial cancers
in three-dimensional cultures,” Nat. Rev. Cancer 5共9兲, 675–688
共2005兲.
2. J. Debnath, K. R. Mills, N. L. Collins, M. J. Reginato, S. K. Muthuswamy, and J. S. Brugge, “The role of apoptosis in creating and
maintaining luminal space within normal and oncogene-expressing
mammary acini,” Cell 111共1兲, 29–40 共2002兲.
3. S. K. Muthuswamy, D. Li, S. Lelievre, M. J. Bissell, and J. S.
Brugge, “ErbB2, but not ErbB1, reinitiates proliferation and induces
luminal repopulation in epithelial acini,” Nat. Cell Biol. 3共9兲, 785–
792 共2001兲.
4. M. J. Bissell, V. M. Weaver, S. A. Lelievre, F. Wang, O. W. Petersen,
and K. L. Schmeichel, “Tissue structure, nuclear organization, and
gene expression in normal and malignant breast,” Cancer Res. 59共7
Suppl.兲, 1757–1763s, discussion 1763s–1764s 共1999兲.
5. T. Ohmori, J. L. Yang, J. O. Price, and C. L. Arteaga, “Blockade of
tumor cell transforming growth factor-betas enhances cell cycle progression and sensitizes human breast carcinoma cells to cytotoxic
chemotherapy,” Exp. Cell Res. 245共2兲, 350–359 共1998兲.
6. J. C. Finlay, S. Mitra, M. S. Patterson, and T. H. Foster, “Photobleaching kinetics of Photofrin in vivo and in multicell tumour
spheroids indicate two simultaneous bleaching mechanisms,” Phys.
Med. Biol. 49共21兲, 4837–4860 共2004兲.
7. C. E. Bigelow, S. Mitra, R. Knuechel, and T. H. Foster, “ALA- and
ALA-hexylester-induced protoporphyrin IX fluorescence and distribution in multicell tumour spheroids,” Br. J. Cancer 85共5兲, 727–734
共2001兲.
8. I. Georgakoudi and T. H. Foster, “Effects of the subcellular redistribution of two nile blue derivatives on photodynamic oxygen consumption,” Photochem. Photobiol. 68共1兲, 115–122 共1998兲.
9. T. H. Foster, D. F. Hartley, M. G. Nichols, and R. Hilf, “Fluence rate
effects in photodynamic therapy of multicell tumor spheroids,” Cancer Res. 53共6兲, 1249–1254 共1993兲.
10. G. Y. Lee, P. A. Kenny, E. H. Lee, and M. J. Bissell, “Three-

051603-9

September/October 2010

쎲

Vol. 15共5兲

Celli et al.: Quantitative imaging reveals heterogeneous growth dynamics and treatment-dependent…

11.
12.
13.

14.
15.

16.

17.
18.
19.
20.

21.

dimensional culture models of normal and malignant breast epithelial
cells,” Nat. Methods 4共4兲, 359–365 共2007兲.
K. R. Cho and I. M. Shih, “Ovarian cancer,” Annu. Rev. Pathol. 4,
287–313 共2009兲.
A. Jemal, R. Siegel, E. Ward, Y. Hao, J. Xu, and M. J. Thun, “Cancer
statistics, 2009,” Ca-Cancer J. Clin. 59共4兲, 225–249 共2009兲.
J. S. Berek and R. C. J. Bast, “Ovarian cancer,” in Cancer Medicine,
D. W. Kufe, R. E. Pollack, R. R. Weichselbaum, R. C. J. Bast, T. S.
Gansler, J. F. Holland, and E. I. Frei, Eds., pp. 1831–1861, BC
Decker, Hamilton, Ontario 共2003兲.
M. J. Bissell and D. Radisky, “Putting tumours in context,” Nat. Rev.
Cancer 1共1兲, 46–54 共2001兲.
J. Debnath, S. K. Muthuswamy, and J. S. Brugge, “Morphogenesis
and oncogenesis of MCF-10A mammary epithelial acini grown in
three-dimensional basement membrane cultures,” Methods 30共3兲,
256–268 共2003兲.
B. Grun, E. Benjamin, J. Sinclair, J. F. Timms, I. J. Jacobs, S. A.
Gayther, and D. Dafou, “Three-dimensional in vitro cell biology
models of ovarian and endometrial cancer,” Cell Prolif 42共2兲, 219–
228 共2009兲.
K. Lawrenson, E. Benjamin, M. Turmaine, I. Jacobs, S. Gayther, and
D. Dafou, “In vitro three-dimensional modelling of human ovarian
surface epithelial cells,” Cell Prolif 42共3兲, 385–393 共2009兲.
K. Fujiwara, “Can carboplatin replace cisplatin for intraperitoneal
use?” Int. J. Gynecol. Cancer 18共Suppl. 1兲, 29–32 共2008兲.
M. Markman, “Pharmaceutical management of ovarian cancer: current status,” Drugs 68共6兲, 771–789 共2008兲.
T. Hasan, B. Ortel, N. Solban, and B. Pogue, “Photodynamic therapy
of cancer,” in Cancer Medicine, D. W. Kufe, R. C. J. Bast, W. N.
Hait, W. K. Hong, R. E. Pollock, R. R. Weichselbaum, J. F. Holland,
and E. I. Frei, Eds., pp. 537–548, BC Decker, Hamilton, Ontario
共2006兲.
S. K. Hendren, S. M. Hahn, F. R. Spitz, T. W. Bauer, S. C. Rubin, T.
Zhu, E. Glatstein, and D. L. Fraker, “Phase II trial of debulking

Journal of Biomedical Optics

22.

23.

24.

25.

26.

27.

28.

29.

051603-10

surgery and photodynamic therapy for disseminated intraperitoneal
tumors,” Ann. Surg. Oncol. 8共1兲, 65–71 共2001兲.
S. M. Hahn, D. L. Fraker, R. Mick, J. Metz, T. M. Busch, D. Smith,
T. Zhu, C. Rodriguez, A. Dimofte, and F. Spitz, “A phase II trial of
intraperitoneal photodynamic therapy for patients with peritoneal carcinomatosis and sarcomatosis,” Clin. Cancer Res. 12共8兲, 2517–2525
共2006兲.
W. Zhong, J. P. Celli, I. Rizvi, Z. Mai, B. Q. Spring, S. H. Yun, and
T. Hasan, “In vivo high-resolution fluorescence microendoscopy for
ovarian cancer detection and treatment monitoring,” Br. J. Cancer
101共12兲, 2015–2022 共2009兲.
M. G. del Carmen, I. Rizvi, Y. Chang, A. C. E. Moor, E. Oliva, M.
Sherwood, B. Pogue, and T. Hasan, “Synergism of epidermal growth
factor receptor-targeted immunotherapy with photodynamic treatment
of ovarian cancer in vivo,” J. Natl. Cancer Inst. 97共20兲, 1516–1524
共2005兲.
K. L. Molpus, M. R. Hamblin, I. Rizvi, and T. Hasan, “Intraperitoneal
photoimmunotherapy of ovarian carcinoma xenografts in nude mice
using charged photoimmunoconjugates,” Gynecol. Oncol. 76共30兲,
397–404 共2000兲.
K. L. Molpus, D. Kato, M. R. Hamblin, L. Lilge, M. Bamberg, and T.
Hasan, “Intraperitoneal photodynamic therapy of human epithelial
ovarian carcinomatosis in a xenograft murine model,” Cancer Res.
56共5兲, 1075–1082 共1996兲.
H. K. Kleinman, M. L. McGarvey, J. R. Hassell, V. L. Star, F. B.
Cannon, G. W. Laurie, and G. R. Martin, “Basement membrane complexes with biological activity,” Biochemistry 25共2兲, 312–318 共1986兲.
C. L. Evans, I. Rizvi, T. Hasan, and J. F. de Boer, “In vitro ovarian
tumor growth and treatment response dynamics visualized with timelapse OCT imaging,” Opt. Express 17共11兲, 8892–8906 共2009兲.
E. Limpert, W. A. Stahel, and M. Abbt, “Log-normal distributions
across the sciences: keys and clues,” BioScience 51共5兲, 341–352
共2001兲.

September/October 2010

쎲

Vol. 15共5兲

